Russian Medical Inquiry
(RMZh. Meditsinskoe Obozrenie) ISSN 2587-6821 (Print), 2686-9918 (Online)

Polyarteritis nodosa: a clinical case report

VAK

Scopus

E-libraryDimensions

russian citation indexULRICHS

roaddoaj

CyberleninkaGoogle Scholar

vinitiResearch4life

MendeleyScilit

РГБWhite list




Open accessCrossrefAntiplagiat

RMJ.ru




DOI: 10.32364/2587-6821-2026-10-3-9


Polyarteritis nodosa: a clinical case report

I.S. Svintsitskaya1, V.A. Likhodkin2, E.S. Ambartsumov3, D.N. Yanishevsky1

1Military Medical Academy, St. Petersburg, Russian Federation

2A.A. Vishnevsky National Medical Research Center of High Medical Technologies   of the Ministry of Defense of Russia, Krasnogorsk, Russian Federation

3MMC VT LLC, Leningrad Region, Yukkovskoye Rural Settlement, Beloostrov Clinic   Territory, Russian Federation

Polyarteritis nodosa (PAN) is a rare systemic necrotizing vasculitis characterized by the predominant involvement of medium- and small-caliber arteries, resulting in ischemic, inflammatory, and thrombotic changes affecting various organs and tissues. The disease is notable for its marked clinical polymorphism, which frequently leads to diagnostic difficulties, delayed diagnosis verification, and repeated revision of clinical hypotheses at different stages of patient follow-up.

This article presents a clinical case of a young patient with childhood-onset disease, a relapsing course, prominent cutaneous, articular, and neurological manifestations, as well as high laboratory inflammatory activity. A retrospective analysis was performed, encompassing anamnestic data, clinical examination findings, and laboratory and instrumental investigation results. Particular attention was given to the evolution of the clinical presentation, dynamics of inflammatory activity markers, development of complications, peripheral nervous system involvement, and response to the administered therapy.

The presented case illustrates the importance of comprehensive clinicopathological assessment, timely diagnostic verification, and early initiation of pathogenetic immunosuppressive therapy. Current approaches to the diagnosis, treatment, prognostic evaluation, relapse prevention, and multidisciplinary management of patients with polyarteritis nodosa are discussed.

Keywords: polyarteritis nodosa, systemic vasculitis, necrotizing arteritis, cutaneous vasculitis, glucocorticosteroids, cyclophosphamide.

For citation: Svintsitskaya I.S., Likhodkin V.A., Ambartsumov E.S., Yanishevsky D.N. Polyarteritis nodosa: a clinical case report. Russian Medical Inquiry. 2026;10(3):168–173 (in Russ.). DOI: 10.32364/2587-6821-2026-10-3-9



About the authors:

Irina S. Svintsitskaya — C. Sc. (Med.), Associate Professor of the Department of Faculty Internal Medicine, Military Medical Academy; 6, Akademika Lebedeva str., St. Petersburg, 194044, Russian Federation; ORCID iD 0000-0002-1317-8276

Vadim A. Likhodkin — Senior Resident of the Rheumatology Department, A.A. Vishnevsky National Medical Research Center of High Medical Technologies of the Ministry of Defense of Russia; 1, Novy Settlement, Krasnogorsk, 143420, Russian Federation; ORCID iD 0000-0001-7651-7709

Eduard S. Ambartsumov — rheumatologist, MMC VT LLC; Build. 1, Block 1, Beloostrov Clinic Territory, Yukkovskoye Rural Settlement, Vsevolozhsky District, Leningrad Region, 188632, Russian Federation; ORCID iD 0000-0003-1505-3263

Daniil N. Yanishevsky — Medical Cadet, Faculty of Physician Training, Military Medical Academy, Ministry of Defense of the Russian Federation; 6, Akademika Lebedeva str., St. Petersburg, 194044, Russian Federation; ORCID iD 0009-0007-3723-6286

Contact information: Irina S. Svintsitskaya, e-mail: sonirinadoc@mail.ru

Financial Disclosure: no authors have a financial or property interest in any material or method mentioned.

There is no conflict of interest.

Received 16.02.2026.

Revised 05.03.2026.

Accepted 27.03.2026.


References
1. Sunderkötter C.H., Zelger B., Chen K.R. et al. Nomenclature of cutaneous vasculitis: dermatologic addendum to the Chapel Hill Consensus Conference nomenclature. Arthritis Rheumatol. 2018;70:171–184. DOI: 10.1002/art.40375
2. Jennette J.C., Falk R.J., Bacon P.A. et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1–11. DOI: 10.1002/art.37715
3. Логвиненко С.И., Ефремова О.А., Придачина Л.С. и др. Узелковый полиартериит (болезнь Куссмауля — Мейера) — трудный диагноз в практике врача-терапевта. Научные ведомости Белгородского государственного университета. Серия: Медицина. Фармация. 2014;(11):258–261.Logvinenko S.I., Efremova O.A., Pridachina L.S. et al. Polyarteritis nodosa (Kussmaul — Maier disease): a difficult diagnosis in physician practice. Nauchnye vedomosti Belgorodskogo gosudarstvennogo universiteta. Seriya: Meditsina. Farmatsiya. 2014;(11):258–261 (in Russ.).
4. De Virgilio A., Greco A., Magliulo G. et al. Polyarteritis nodosa: a contemporary overview. Autoimmun Rev. 2016;15:564–570. DOI: 10.1016/j.autrev.2016.02.015
5. Mahr A., Guillevin L., Poissonnet M., Aymé S. Prevalences of polyarteritis nodosa and related vasculitides in a French population. Arthritis Rheum. 2004;51:92–99. DOI: 10.1002/art.20077
6. Pagnoux C., Seror R., Henegar C. et al. Clinical features and outcomes in polyarteritis nodosa. Arthritis Rheum. 2010;62:616–626. DOI: 10.1002/art.27240
7. Caratsch L., Schnider C., Moi L. et al. Adenosine deaminase 2 deficiency: a disease with multiple presentations. Rev Med Suisse. 2022;18:669–673. DOI: 10.53738/REVMED.2022.18.776.669
8. Saadoun D., Terrier B., Semoun O. et al. Hepatitis C virus-associated polyarteritis nodosa. Arthritis Care Res. 2010;63:427–435. DOI: 10.1002/acr.20381
9. Patel N., Patel N., Khan T. et al. HIV infection and clinical spectrum of associated vasculitides. Curr Rheumatol Rep. 2011;13:506–512. DOI: 10.1007/s11926-011-0214-6
10. Beck D.B., Ferrada M.A., Sikora K.A. et al. Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med. 2020;383:2628–2638. DOI: 10.1056/NEJMoa2026834
11. Boyadzhieva Z., Ruffer N., Kötter I., Krusche M. Treatment strategies in VEXAS syndrome. Rheumatology (Oxford). 2023;62:3518–3525. DOI: 10.1093/rheumatology/kead240
12. De Boysson H., Guillevin L. Polyarteritis nodosa: neurologic manifestations. Neurol Clin. 2019;37:345–357. DOI: 10.1016/j.ncl.2019.01.007
13. Morgan A.J., Schwartz R.A. Cutaneous polyarteritis nodosa: a comprehensive review. Int J Dermatol. 2010;49:750–756. DOI: 10.1111/j.1365-4632.2010.04522.x
14. Levine S.M., Hellmann D.B., Stone J.H. Gastrointestinal involvement in polyarteritis nodosa. Am J Med. 2002;112:386–391. DOI: 10.1016/S0002-9343(01)01131-7
15. Gendreau S., Porcher R., Thoreau B. et al. Risk factors for poor outcome in systemic vasculitis. Semin Arthritis Rheum. 2021;51:436–441. DOI: 10.1016/j.semarthrit.2021.03.002
16. Teichman J.M., Mattrey R.F., Demby A.M., Schmidt J.D. Polyarteritis nodosa presenting as acute orchitis. J Urol. 1993;149:1139–1140. DOI: 10.1016/S0022-5347(17)36322-X
17. Chung S.A., Gorelik M., Langford C.A. et al. 2021 ACR/VF guideline for the management of polyarteritis nodosa. Arthritis Rheumatol. 2021;73:1384–1393. DOI: 10.1002/art.41776

License Creative Commons
This work is licensed under a Creative Commons «Attribution» 4.0 License.


Previous article
Next article